When psychiatric disorders become complex and their symptoms severe, traditional treatments may not always be sufficient to achieve the desired improvement. In such cases, Electroconvulsive Therapy (ECT) is considered a specialized treatment option that has demonstrated its importance in managing certain severe psychiatric conditions.Although the term “electroconvulsive therapy” may initially cause concern or create an inaccurate impression of the procedure, modern medicine has made ECT a more precise and controlled treatment. It is performed under general anesthesia using specialized equipment, with careful monitoring of the patient throughout all stages of the session.ECT is used in specific situations, most notably severe depression, catatonia, and certain cases of mania and psychotic disorders, particularly when symptoms are severe or when a rapid therapeutic response is needed. Understanding ECT involves more than simply knowing how the electrical stimulus is administered; it also includes understanding its purpose, indications, procedure, expected outcomes, potential side effects, and necessary precautions.In this comprehensive article, Dalili Medical explores electroconvulsive therapy in detail, beginning with its definition and therapeutic goals, followed by how the procedure is performed and the different types of ECT used. The article also discusses expected outcomes, potential risks, and important precautions, providing a clear and balanced overview of this important treatment approach in modern psychiatry.
Electroconvulsive Therapy (ECT) is a medical procedure performed under general anesthesia to treat certain severe psychiatric disorders, particularly conditions that require rapid improvement or have not responded adequately to other treatments. The therapy involves delivering a carefully calculated and controlled electrical current through electrodes placed on the scalp to induce a brief, medically supervised therapeutic seizure. This process produces changes in brain activity that may help improve psychiatric and mood-related symptoms.
ECT is performed by a specialized medical team, with careful monitoring of the patient's vital signs during and after the procedure. This makes it a highly controlled medical treatment that differs significantly from common misconceptions about “electric shocks.”
Patients generally do not feel the electrical stimulus during the procedure because they are under short-acting general anesthesia. A muscle relaxant is also administered. After waking up, some patients may experience temporary side effects such as headache, nausea, or muscle soreness.
No. The patient is under general anesthesia while the electrical stimulation is administered and gradually regains consciousness during the recovery period after the procedure.
No. The seizure induced during ECT is an intentional, controlled therapeutic seizure performed under close medical supervision. It does not mean that the patient has epilepsy.
The electrical stimulation itself takes only a short amount of time. However, the total time spent in the treatment unit is longer because it includes preparation before anesthesia, the procedure itself, and monitoring during recovery. The duration varies from patient to patient depending on their condition and the protocol followed by the medical facility.
There is no fixed number of sessions that is appropriate for everyone. The number depends on the type of psychiatric disorder, severity of symptoms, response to treatment, and side effects. Some patients require a series of sessions to achieve the desired improvement, with their condition continuously reassessed by the treating team.
ECT may cause temporary memory problems, which are among its most recognized side effects. Some patients may have difficulty remembering events that occurred around the time of treatment, while gaps in certain previous memories may also occur. In most cases, memory gradually improves over time; however, some patients may experience persistent gaps in certain memories.
Current medical evidence does not indicate that ECT causes permanent structural brain damage as a typical consequence of treatment. However, some patients may experience persistent memory difficulties. For this reason, the medical team carefully weighs the potential benefits against the risks and regularly monitors the patient's cognitive function.
ECT may be used in children and adolescents in certain severe and specific circumstances. However, its use in this age group is limited and requires a thorough assessment by a specialized multidisciplinary team. The patient's medical and psychiatric condition, as well as the appropriate consent and legal requirements, must also be taken into consideration.
ECT may be considered during pregnancy in certain situations, particularly when the psychiatric condition is severe or when rapid improvement is medically necessary. The decision requires a careful multidisciplinary assessment involving psychiatry, anesthesiology, and obstetrics, with consideration given to the safety of both the mother and the fetus.
Electroconvulsive Therapy (ECT) is a medical procedure performed under general anesthesia to treat certain severe psychiatric disorders, particularly conditions that require rapid improvement or have not responded adequately to other treatments.
ECT involves delivering a carefully controlled electrical stimulus through electrodes placed on the scalp. The stimulus is intended to produce a brief, medically controlled therapeutic seizure, which causes changes in brain activity that may help improve psychiatric and mood symptoms.
The procedure is performed by a specialized medical team, with careful monitoring of vital signs during and after the session. This makes modern ECT a highly controlled medical procedure that differs considerably from common misconceptions about “electrical shocks.”
Usually, patients do not feel the electrical stimulation because they are under short-acting general anesthesia. A muscle relaxant is also administered. After waking up, some patients may experience temporary symptoms such as headache, nausea, or muscle soreness.
No. The patient is under general anesthesia during the electrical stimulation and gradually regains consciousness during the recovery period after the procedure.
No. The seizure produced during ECT is an intentionally induced and medically controlled therapeutic seizure. It does not mean that the patient has epilepsy.
The electrical stimulation itself lasts only a short time. However, the total time spent in the ECT unit is longer because the patient needs preparation before anesthesia, the procedure itself, and monitoring during recovery. The duration varies depending on the patient's condition and the protocol used by the medical center.
There is no fixed number of sessions that applies to every patient. The number depends on the psychiatric disorder, symptom severity, treatment response, and side effects. Some patients require a series of sessions to achieve the desired improvement, with regular reassessment by the treatment team.
ECT may cause temporary memory problems, which are among its most recognized side effects. Some patients may have difficulty remembering events around the time of treatment, while gaps in certain previous memories may also occur.
In many cases, memory gradually improves over time. However, some patients may experience persistent loss of certain memories.
Available medical evidence does not indicate that ECT routinely causes permanent structural brain damage. However, some patients may experience persistent memory difficulties. For this reason, healthcare professionals carefully balance the potential benefits of treatment against its possible risks and monitor cognitive function throughout treatment.
ECT can be used in children and adolescents in certain severe circumstances, but its use in this age group is limited. It requires careful assessment by a specialized team, taking into account the patient's medical and psychiatric condition and the appropriate consent and regulatory requirements.
ECT may be considered during pregnancy in certain situations, particularly when the psychiatric condition is severe or rapid improvement is needed. The decision should be made after careful assessment by a multidisciplinary team that may include psychiatrists, anesthesiologists, and obstetric specialists, with consideration of both maternal and fetal safety.
ECT is generally not the first-line treatment for routine cases of depression. Medication and psychotherapy are usually considered first. However, ECT may become an important treatment option when depression is severe, rapid improvement is needed, or other treatments have not produced an adequate response.
Yes. Some patients may experience a relapse after completing an acute course of ECT. Doctors may therefore recommend ongoing medication or psychotherapy. In some cases, continuation or maintenance ECT may be used to help maintain improvement and reduce the risk of relapse.
In many cases, patients can go home after the session once they have fully recovered from anesthesia and their physical condition is stable. Patients should follow the instructions provided by the treatment center.
Because anesthesia and temporary confusion or memory problems may affect the patient, they may need someone to accompany them home and should not drive or operate machinery immediately after treatment.
Patients are generally advised not to drive immediately after ECT because of the effects of anesthesia and the possibility of temporary drowsiness, confusion, or memory impairment.
The period during which driving should be avoided depends on the patient's condition, the treating physician's instructions, and local regulations.
ECT is generally considered a relatively safe medical procedure when performed in an appropriately equipped medical facility by a specialized team. However, like any procedure involving general anesthesia, it carries some risks.
Temporary changes in blood pressure and heart rate can occur, which is why patients are closely monitored during and after treatment. Serious complications are uncommon, but the level of risk varies depending on the patient's overall health.
No. Patients generally do not need to shave their heads before ECT. The electrodes are placed on the scalp, and an appropriate conductive material may be used to facilitate delivery of the electrical stimulus.
The treatment center may ask the patient to clean certain areas of the scalp or avoid certain hair products, but completely shaving the head is not normally required.
ECT is intended to reduce psychiatric symptoms and improve the patient's condition, and it can be particularly useful in certain severe psychiatric disorders.
However, temporary side effects such as confusion, headache, and memory problems may occur, and not every patient responds to treatment in the same way. The treatment team therefore monitors the patient regularly and reassesses the balance between benefits and side effects throughout the course of treatment.
ECT can be classified according to several medical factors, including electrode placement, electrical pulse characteristics, and the purpose and duration of treatment. The appropriate approach is selected based on the patient's condition, symptom severity, treatment response, and potential side effects.
In bilateral ECT, the electrodes are placed on both sides of the head, allowing stimulation involving both cerebral hemispheres.
This approach may be used in some severe cases or when a rapid therapeutic response is needed. However, it may be associated with a greater likelihood of certain cognitive effects, particularly memory difficulties, compared with some forms of unilateral ECT.
In unilateral ECT, the electrodes are placed on one side of the head, often on the side that is considered nondominant.
The anesthesia, monitoring, and stimulation procedures are generally similar to those used with bilateral ECT, with the main difference being electrode placement.
This approach may be selected to reduce certain cognitive effects, particularly memory problems, while maintaining therapeutic effectiveness. Its effectiveness depends on factors such as stimulus dose, pulse characteristics, and the patient's clinical condition.
Other electrode configurations may also be used in specific circumstances, depending on the patient's condition, the ECT device, and the treatment protocol.
This technique uses short-duration electrical pulses during stimulation. It is one of the commonly used approaches with modern ECT devices.
The treatment team can adjust the stimulation parameters according to the patient's clinical condition and seizure threshold.
Ultrabrief-pulse ECT uses electrical pulses that are shorter than those used in brief-pulse ECT.
It may be considered in some patients with the goal of achieving therapeutic effects while reducing certain cognitive side effects, particularly memory-related effects. The choice depends on factors such as symptom severity, the need for a rapid response, and the clinician's assessment of potential benefits and risks.
Sine-wave stimulation was used more commonly during earlier stages of ECT development. It has become less common with the development of modern brief-pulse techniques, which provide greater control over electrical stimulation and may be associated with fewer cognitive side effects.
Acute ECT consists of a series of sessions intended to control a severe psychiatric episode, such as severe depression or catatonia, and achieve significant improvement in symptoms.
Continuation ECT is used after an initial improvement has been achieved. Sessions are usually given less frequently, with the goal of maintaining improvement and reducing the likelihood of relapse during the following period.
Maintenance ECT is administered over a longer period at increasingly spaced intervals in some patients who have a recurrent illness. It may help maintain psychiatric stability and reduce the likelihood of symptom recurrence.
ECT is used for selected severe psychiatric conditions, particularly when symptoms are severe, rapid improvement is needed, or medication and psychotherapy have not produced an adequate response.
The decision to use ECT is made after a comprehensive assessment of the patient's condition and a careful consideration of the potential benefits, risks, and side effects.
Severe depression is one of the main indications for ECT, particularly when accompanied by circumstances requiring rapid intervention, such as:
Suicidal thoughts or attempts, particularly when suicide risk is high.
Psychotic symptoms, such as hallucinations or delusions associated with depression.
Refusal to eat or drink or severe deterioration in the ability to care for oneself.
Inadequate response to several types of medication or psychotherapy.
Inability to tolerate certain antidepressants or medical reasons that make their use inappropriate.
Catatonia is a syndrome that can occur alongside various psychiatric and medical disorders. It may involve:
Markedly reduced movement or responsiveness.
Mutism or significantly reduced speech.
Prolonged staring or remaining in a fixed position.
Refusal to eat or drink.
Abnormal postures that are maintained for extended periods.
Non-purposeful movements or severe agitation in some cases.
In severe catatonia, or when the condition does not respond to initial treatment, ECT may be an important treatment option and may need to be initiated promptly depending on the clinical assessment.
ECT may be considered in certain cases of severe mania, particularly when symptoms are severe or do not respond adequately to medication. Situations in which it may be considered include:
Severe agitation.
Psychotic symptoms.
Severe dangerous or impulsive behavior.
Inability to take medication or cooperate with treatment.
A need for rapid improvement.
ECT is generally not considered the first-line treatment for schizophrenia, but it may be used in selected situations, including:
Severe cases that have not responded adequately to medication.
Schizophrenia accompanied by catatonia.
Certain cases associated with severe affective symptoms or severe agitation.
The need for rapid improvement is an important factor when considering ECT. In some severe conditions, it may not be appropriate to wait several weeks for the full effects of medication to develop.
Examples include severe depression accompanied by a high risk of suicide, refusal of food or fluids, or severe catatonia.
ECT can be classified according to several factors, particularly electrode placement, electrical pulse type, and the purpose and duration of treatment.
The medical team selects the appropriate approach based on the patient's psychiatric and physical condition, symptom severity, treatment response, and potential side effects.
In bilateral ECT, electrodes are placed on both sides of the head so that the electrical stimulation involves both cerebral hemispheres.
The patient receives short-acting general anesthesia.
A muscle relaxant is administered, and equipment is used to monitor the heart, breathing, and oxygen saturation.
The electrodes are positioned at the appropriate locations on the scalp.
The physician determines the stimulation dose based on clinical factors and the patient's response.
A controlled therapeutic seizure is induced under continuous medical monitoring.
After stimulation, the patient is transferred to the recovery area, where they are monitored until they regain consciousness and become medically stable.
One characteristic of bilateral ECT is that it may be appropriate for certain patients who require a rapid therapeutic response. However, it may be associated with cognitive effects, particularly memory difficulties, to a greater degree in some patients compared with certain unilateral approaches.
In unilateral ECT, the electrodes are placed on one side of the head, often on the nondominant side of the brain.
The anesthesia, monitoring, and stimulation procedures are generally similar to those used in bilateral ECT. The primary difference is the placement of the electrodes.
This approach may be selected with the aim of reducing certain cognitive effects, particularly memory difficulties, while maintaining therapeutic efficacy. Its effectiveness varies depending on the stimulus dose, pulse type, and the patient's clinical condition.
This technique uses short-duration electrical pulses during stimulation. It is one of the commonly used techniques in modern ECT devices.
The physician can adjust the stimulation parameters according to the patient's condition and therapeutic seizure threshold.
This technique uses electrical pulses that are shorter than those used in brief-pulse ECT.
It may be used in certain cases with the goal of achieving therapeutic effects while minimizing some cognitive effects, particularly those associated with memory.
The choice depends on several factors, including the severity of the condition, the required speed of response, and the physician's assessment of the potential benefits and risks.
Sine-wave stimulation was more commonly used during earlier stages of ECT development. However, it has become less common with the development of modern brief-pulse techniques, which provide greater control over electrical stimulation and may be associated with fewer cognitive side effects.
Acute ECT consists of a series of treatment sessions aimed at controlling an acute psychiatric episode and achieving significant improvement in symptoms, such as severe depression, catatonia, or certain cases of severe mania.
Continuation ECT is used after initial improvement has been achieved. Sessions are usually less frequent than during the acute treatment phase. The goal is to maintain the improvement and reduce the likelihood of symptom recurrence during the period following acute treatment.
Maintenance ECT is provided over a longer period at spaced intervals for some patients who have a history of recurrent episodes or who have shown clear benefit from ECT. The goal is to maintain psychiatric stability and reduce the likelihood of recurrent episodes.
ECT is performed in a specialized medical unit under the supervision of a team that may include psychiatrists, nurses, anesthesiologists, and other healthcare professionals. The treatment day generally consists of several stages, beginning with preparation and assessment, followed by the procedure under anesthesia, and ending with recovery and monitoring.
If the patient is hospitalized, a member of the medical team accompanies them to the ECT unit, where the team explains the procedure and answers any questions. At some centers, a family member may wait in a designated waiting area during treatment, depending on the facility's policies.
Before the session, the patient meets with a member of the ECT team. Routine medical assessments are performed if they have not already been completed. The patient may also be asked about their general condition, memory, and cognitive function to monitor for any changes during treatment.
If the patient has voluntarily consented to ECT, the medical team confirms that they still wish to proceed and gives them an opportunity to ask any additional questions or express concerns.
Once preparation is complete, the patient is taken to the treatment room.
The patient is connected to monitoring equipment to assess their condition throughout the procedure. This usually includes monitoring of:
Heart rate.
Blood pressure.
Blood oxygen saturation.
Brain electrical activity using electroencephalography (EEG).
The patient is also given oxygen through a mask. The anesthesiologist then administers a short-acting general anesthetic intravenously, usually through an intravenous cannula placed in the hand.
After the patient is under anesthesia, a muscle relaxant is administered. A mouth guard is also used to help protect the teeth during the procedure.
Electrodes are then positioned on the scalp according to the type of ECT being used. In bilateral ECT, the electrodes are placed on both sides of the head, whereas in unilateral ECT, they are positioned on one side.
The ECT machine then delivers brief, controlled electrical pulses intended to produce a short, medically monitored therapeutic seizure. The treatment team adjusts the stimulation parameters according to the patient's response and the clinical criteria being used.
Because a muscle relaxant is administered, physical movements during the seizure are limited. Brain electrical activity and vital signs are continuously monitored throughout the procedure.
After stimulation ends, the effects of the anesthetic and muscle relaxant gradually wear off. The patient is then transferred to a recovery area, where a nurse or another member of the medical team monitors them until they regain sufficient consciousness.
Blood pressure, heart rate, and oxygen saturation are monitored, and supplemental oxygen may be continued for a short period.
When waking up, the patient may experience drowsiness or temporary confusion and may initially be unsure of where they are or what happened during the session.
This confusion usually improves gradually over a short period. The medical team may ask simple questions to assess the patient's level of consciousness and alertness.
Once the patient is medically stable and sufficiently alert, they may move to a designated recovery area, where they can have a drink or a light snack according to the medical team's instructions.
The patient is allowed to leave the ECT unit once the medical team confirms that their condition is stable and that it is safe for them to leave.
The procedure itself is relatively brief. However, the total time spent in the treatment unit is longer because it includes preparation, anesthesia, the procedure, and recovery.
The entire process may take approximately one hour, although the duration varies between medical centers and individual patients.
Because of the effects of anesthesia and the possibility of temporary confusion or memory impairment, patients should follow the instructions provided by their treatment team after the session.
They may be advised to:
Avoid driving or operating machinery.
Avoid consuming alcohol.
Avoid making important decisions or signing legal documents for the period specified by the physician.
Have a responsible adult accompany them after returning home, according to the medical center's instructions.
ECT is generally considered a relatively safe medical procedure when performed in a specialized facility under the supervision of a qualified medical team, with general anesthesia and continuous monitoring.
However, like any medical procedure, ECT may be associated with side effects and risks, which can vary from one patient to another.
Memory difficulties are among the most recognized side effects associated with ECT. They may include:
Forgetting some events that occurred around the time of treatment.
Difficulty remembering certain events that occurred during the treatment period.
Gaps in some memories from before treatment, which may extend over a longer period in some patients.
Memory problems often improve gradually during the weeks or months following treatment. However, some patients may notice persistent gaps in certain memories.
The likelihood and severity of cognitive effects can vary depending on the treatment technique, treatment parameters, and number of sessions. Therefore, the medical team monitors cognitive function throughout treatment and may modify the treatment approach if significant problems develop.
After waking from anesthesia, the patient may experience temporary confusion. This may include:
Temporary difficulty identifying their location or the time.
Drowsiness or slowed responses.
Difficulty remembering what happened immediately before or after the session.
This confusion generally improves gradually over a short period. However, its duration and severity vary from person to person and may be more noticeable in some older adults.
Some physical symptoms may occur after an ECT session, including:
Headache.
Nausea or vomiting.
Muscle soreness.
Jaw pain or discomfort.
Fatigue and drowsiness related to anesthesia.
These symptoms are usually temporary and can be managed by the medical team using appropriate supportive measures or medications when necessary.
ECT may cause temporary changes in heart rate and blood pressure during the session. For this reason, heart function, blood pressure, and oxygen saturation are continuously monitored.
Patients with significant cardiovascular disease require careful medical assessment before treatment to determine whether ECT is appropriate and to establish any necessary precautions.
Because ECT is performed under short-acting general anesthesia, it also carries the usual risks associated with general anesthesia.
The anesthesiologist therefore evaluates the patient's overall health before each session and reviews their medications, chronic medical conditions, and other factors that may affect the safety of anesthesia.
Some rare complications may occur with ECT, including a prolonged seizure or other medical complications.
For this reason, ECT is performed in an appropriately equipped medical setting under continuous monitoring, with a medical team available to provide immediate intervention if complications occur.
The results of ECT are not assessed using a single number or one test. Instead, the physician considers a combination of psychiatric, clinical, and cognitive indicators, along with the patient's response throughout the course of treatment.
The goal is to determine how effective the treatment is, monitor side effects, and decide whether treatment should continue or whether the treatment approach needs to be modified.
Before treatment begins, the physician assesses and documents the severity of the patient's psychiatric symptoms. The patient's condition is then compared throughout and after treatment.
Standardized clinical scales may be used, including:
Hamilton Depression Rating Scale (HAM-D) or Patient Health Questionnaire-9 (PHQ-9) to assess the severity of depressive symptoms.
Young Mania Rating Scale (YMRS) to assess the severity of manic symptoms.
Bush–Francis Catatonia Rating Scale to assess symptoms of catatonia.
A reduction in the score accompanied by clinical improvement may indicate a response to treatment. However, interpretation depends on the specific scale used and the individual patient's clinical condition.
During the session, brain electrical activity is monitored using electroencephalography (EEG), along with vital signs such as heart rate, blood pressure, and oxygen saturation.
The medical team focuses on ensuring that an appropriate, controlled therapeutic seizure occurs in terms of its electrical activity and duration, rather than simply confirming that electrical current was delivered.
Patients and non-specialists should not attempt to interpret EEG findings or determine the appropriate stimulation dose independently. These findings must be interpreted in the context of anesthesia, the patient's seizure threshold, the device settings, and the treatment protocol being used.
After each session, the medical team monitors changes in the patient's symptoms, including:
Improvement in mood.
Reduction in suicidal thoughts, when present.
Improvement in sleep, appetite, and energy levels.
Reduction in hallucinations or delusions when psychotic symptoms are present.
Improvement in movement and communication in patients with catatonia.
Any side effects or new changes in the patient's condition.
This ongoing assessment helps determine the patient's response to treatment and guides decisions regarding subsequent sessions.
Assessment of cognitive function is an important part of ECT monitoring, particularly memory. The medical team monitors for:
Forgetfulness.
Difficulty with concentration and attention.
Confusion after the session.
Difficulty remembering certain events or information.
Cognitive changes that interfere with daily activities.
If significant cognitive problems develop, the physician may reassess the treatment technique, stimulation dose, or frequency of sessions according to the patient's condition.
ECT is considered effective when there is clear and sustained improvement in the symptoms for which the treatment was prescribed, while side effects remain at a medically manageable and tolerable level.
Treatment success is not determined by the outcome of a single session. Instead, the physician evaluates the overall change in the patient's condition across the course of treatment, comparing their status before, during, and after ECT.
What's your complaint?